îæ€çŽ¢
îæ€çŽ¢
î
Akoustis Technologies Ord Shs
AKTSîãŠã©ãããªã¹ãã«è¿œå
16.715USD
+0.295+1.80%
çµå€Â 10-21 16:00ïŒETïŒ
892.58Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
Akoustis Technologies Ord Shsã«ã€ã㊠äŒæ¥å
Aktis Oncology Inc is a United States-based biotechnology company. The Company focuses on developing targeted radiopharmaceuticals for treating solid tumor cancers. It also aims to deliver high doses of radiation directly to tumors, minimizing harm to healthy tissue. It transforms cancer care with novel platform technologies that enables to design and develop precision for radiopharmaceuticals. Its drugs are designed to bind to specific proteins on cancer cells, delivering radiation directly to the tumor.
Akoustis Technologies Ord Shs ãããã£ãŒã«
îäŒæ¥ã³ãŒãAKTS
äŒç€ŸåAktis Oncology Inc
äžå Žæ¥Jan 09, 2026
æé«çµå¶è²¬ä»»è
ãCEOãRoden (Matthew)
åŸæ¥å¡æ°117
蚌åžçš®é¡Ordinary Share
決ç®ææ«Jan 09
æ¬ç€Ÿæåšå°17 Drydock Avenue
éœåžBOSTON
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·02210
é»è©±çªå·13026587581
ãŠã§ããµã€ãhttps://www.aktisoncology.com/
äŒæ¥ã³ãŒãAKTS
äžå Žæ¥Jan 09, 2026
æé«çµå¶è²¬ä»»è
ãCEOãRoden (Matthew)
Akoustis Technologies Ord Shsã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Matthew (Matt) Roden, Ph.D.
Dr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Arthur E. Geiss, Ph.D.
Mr. Arthur E. Geiss, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Jerry D. Neal, Ph.D.
Dr. Jerry D. Neal, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Paul L. Feldman, Ph.D.
Dr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Ms. Jill K. Frizzley
Ms. Jill K. Frizzley
Independent Director
Independent Director
--
--
Mr. Matthew R. Kahn, CPA
Mr. Matthew R. Kahn, CPA
Independent Director
Independent Director
--
--
Mr. Todd Foley
Mr. Todd Foley
Chairman of the Board
Chairman of the Board
--
-100.00%
Ms. Shulamit Ron-Bigger, Ph.D.
Ms. Shulamit Ron-Bigger, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Kyle D. Kuvalanka
Mr. Kyle D. Kuvalanka
Chief Financial Officer
Chief Financial Officer
--
--
詳现ãèŠã
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Dr. Matthew (Matt) Roden, Ph.D.
Dr. Matthew (Matt) Roden, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
91.99K
-0.01%
Mr. Arthur E. Geiss, Ph.D.
Mr. Arthur E. Geiss, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Jerry D. Neal, Ph.D.
Dr. Jerry D. Neal, Ph.D.
Independent Co-Chairman of the Board
Independent Co-Chairman of the Board
--
--
Dr. Paul L. Feldman, Ph.D.
Dr. Paul L. Feldman, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Tyler Benedum, Ph.D.
Mr. Tyler Benedum, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Ms. Jill K. Frizzley
Ms. Jill K. Frizzley
Independent Director
Independent Director
--
--
ãããã質å
Akoustis Technologies Ord Shsã®äžäœ5åã®æ ªäž»ã¯èª°ã§ããïŒ
îAkoustis Technologies Ord Shsã®äžäœ5åã®æ ªäž»ã¯ä»¥äžã®ãšããã§ããDr. Matthew (Matt) Roden, Ph.D.
Akoustis Technologies Ord ShsïŒAKTSïŒã®æ ªåŒãä¿æããŠããæ©é¢ã®æ°ã¯ããã€ã§ããïŒ
î2026Q1æç¹ã§ãAkoustis Technologies Ord Shsã®æ ªåŒãä¿æããŠããæ©é¢ã¯195瀟ãããä¿ææ ªåŒã®ç·åžå ŽäŸ¡å€ã¯çŽ27.52Mã§ãå
šäœã®51.47%ãå ããŠããŸãã2025Q4ãšæ¯èŒããŠãæ©é¢ã®æã¡æ ªã¯1127277.00å¢å ããŠããŸãã